CLX · Clorox Co /De/ - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.67B | $1.67B | $1.43B | $1.69B | $1.67B | $1.76B | $1.99B | $1.81B | $1.39B | $1.72B |
| Cost of Revenue | $948.00M | $951.00M | $833.00M | $948.00M | $924.00M | $955.00M | $1.12B | $1.05B | $854.00M | $1.09B |
| Gross Profit | $722.00M | $722.00M | $596.00M | $738.00M | $744.00M | $807.00M | $866.00M | $766.00M | $532.00M | $620.00M |
| R&D | $27.00M | $29.00M | $28.00M | $31.00M | $27.00M | $31.00M | $32.00M | $32.00M | $29.00M | $33.00M |
| SG&A | $229.00M | $262.00M | $277.00M | $280.00M | $267.00M | $281.00M | $322.00M | $301.00M | $276.00M | $282.00M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $58.00M | $53.00M | $56.00M | - | - | $54.00M | - | - | $61.00M | - |
| Operating Income | $256.00M | $215.00M | $107.00M | $237.00M | $254.00M | $177.00M | $136.00M | ($42.00M) | $29.00M | $130.00M |
| Interest Expense | $27.00M | $25.00M | $23.00M | $22.00M | $23.00M | $21.00M | $26.00M | $22.00M | $21.00M | $23.00M |
| Income Tax | $65.00M | $54.00M | $25.00M | $43.00M | $63.00M | $74.00M | $40.00M | $8.00M | $4.00M | $28.00M |
| Net Income | $187.00M | $157.00M | $80.00M | $193.00M | $186.00M | $99.00M | $93.00M | ($51.00M) | $22.00M | $99.00M |
| EPS - Basic | $1.54 | $1.29 | $0.65 | $1.55 | $1.51 | $0.80 | $0.75 | ($0.41) | $0.17 | $0.81 |
| EPS - Diluted | $1.54 | $1.29 | $0.65 | $1.54 | $1.50 | $0.80 | $0.75 | ($0.41) | $0.17 | $0.80 |
Balance Sheet
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.19B | $227.00M | $166.00M | $167.00M | $226.00M | $278.00M | $202.00M | $219.00M | $518.00M | $367.00M |
| Accounts Receivable | $671.00M | $671.00M | $703.00M | $821.00M | $597.00M | $595.00M | $695.00M | $673.00M | $581.00M | $688.00M |
| Inventory | $588.00M | $608.00M | $577.00M | $523.00M | $635.00M | $594.00M | $637.00M | $674.00M | $710.00M | $696.00M |
| Accounts Payable | - | - | - | $838.00M | - | - | $950.00M | - | - | $1.02B |
| Current Assets | $2.65B | $1.73B | $1.70B | $1.61B | $1.59B | $1.58B | $1.62B | $1.66B | $1.91B | $1.83B |
| Total Assets | $6.44B | $5.61B | $5.53B | $5.56B | $5.51B | $5.50B | $5.75B | $5.80B | $5.99B | $5.95B |
| Current Liabilities | $3.15B | $2.35B | $2.23B | $1.92B | $2.15B | $1.58B | $1.57B | $1.85B | $2.23B | $1.92B |
| Long-term Debt | $2.49B | $2.49B | $2.48B | $2.48B | $2.48B | $2.48B | $2.48B | $2.48B | $2.48B | $2.48B |
| Total Liabilities | $6.34B | $5.58B | $5.39B | $5.08B | $5.32B | $5.27B | $5.26B | $5.55B | $5.86B | $5.56B |
| Stockholders' Equity | ($67.00M) | ($125.00M) | ($22.00M) | $321.00M | $27.00M | $60.00M | $328.00M | $91.00M | ($37.00M) | $220.00M |
| Retained Earnings | $223.00M | $190.00M | $200.00M | $432.00M | $99.00M | $31.00M | $250.00M | $34.00M | $299.00M | $583.00M |
Cash Flow
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $93.00M | - | - | $221.00M | - | - | $20.00M | - |
| Investing Cash Flow | - | - | ($34.00M) | - | - | $89.00M | - | - | ($23.00M) | - |
| Financing Cash Flow | - | - | ($59.00M) | - | - | ($237.00M) | - | - | $155.00M | - |
| CapEx | - | - | $36.00M | - | - | $39.00M | - | - | $24.00M | - |
| Free Cash Flow | - | - | $57.00M | - | - | $182.00M | - | - | ($4.00M) | - |
Ratios
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 43.2% | 43.2% | 41.7% | 43.8% | 44.6% | 45.8% | 43.5% | 42.2% | 38.4% | 36.2% |
| Operating margin | 15.3% | 12.9% | 7.5% | 14.1% | 15.2% | 10.0% | 6.8% | -2.3% | 2.1% | 7.6% |
| EBITDA margin | 18.8% | 16.0% | 11.4% | - | - | 13.1% | - | - | 6.5% | - |
| Net margin | 11.2% | 9.4% | 5.6% | 11.4% | 11.2% | 5.6% | 4.7% | -2.8% | 1.6% | 5.8% |
| Free cash flow margin | - | - | 4.0% | - | - | 10.3% | - | - | -0.3% | - |
| FCF / Net income | - | - | 0.71 | - | - | 1.84 | - | - | -0.18 | - |
| R&D / Revenue | 1.6% | 1.7% | 2.0% | 1.8% | 1.6% | 1.8% | 1.6% | 1.8% | 2.1% | 1.9% |
| SG&A / Revenue | 13.7% | 15.7% | 19.4% | 16.6% | 16.0% | 15.9% | 16.2% | 16.6% | 19.9% | 16.4% |
| Effective tax rate | 25.8% | 25.6% | 23.8% | 18.2% | 25.3% | 42.8% | 30.1% | - | 15.4% | 22.0% |
| Return on assets | 2.9% | 2.8% | 1.4% | 3.5% | 3.4% | 1.8% | 1.6% | -0.9% | 0.4% | 1.7% |
| Return on equity | -279.1% | -125.6% | -363.6% | 60.1% | 688.9% | 165.0% | 28.4% | -56.0% | -59.5% | 45.0% |
| Return on invested capital | 7.8% | 6.8% | 3.3% | 6.9% | 7.6% | 4.0% | 3.4% | -1.3% | 1.0% | 3.8% |
| Liquidity | ||||||||||
| Current ratio | 0.84 | 0.74 | 0.76 | 0.84 | 0.74 | 1.00 | 1.03 | 0.90 | 0.86 | 0.95 |
| Quick ratio | 0.65 | 0.48 | 0.50 | 0.57 | 0.44 | 0.62 | 0.63 | 0.53 | 0.54 | 0.59 |
| Cash ratio | 0.38 | 0.10 | 0.07 | 0.09 | 0.10 | 0.18 | 0.13 | 0.12 | 0.23 | 0.19 |
| Leverage | ||||||||||
| Debt / Equity | -37.12 | -19.89 | -112.95 | 7.74 | 91.96 | 41.37 | 7.56 | 27.25 | -66.97 | 11.26 |
| Debt / Assets | 0.39 | 0.44 | 0.45 | 0.45 | 0.45 | 0.45 | 0.43 | 0.43 | 0.41 | 0.42 |
| Debt / EBITDA | 7.92 | 9.28 | 15.25 | - | - | 10.74 | - | - | 27.53 | - |
| Interest coverage | 9.5x | 8.6x | 4.7x | 10.8x | 11.0x | 8.4x | 5.2x | -1.9x | 1.4x | 5.7x |
| Equity multiplier | -96.06 | -44.90 | -251.27 | 17.32 | 204.15 | 91.62 | 17.53 | 63.79 | -161.92 | 27.02 |
| Liabilities / Assets | 0.99 | 0.99 | 0.98 | 0.91 | 0.97 | 0.96 | 0.91 | 0.96 | 0.98 | 0.93 |
| Efficiency | ||||||||||
| Asset turnover | 0.26 | 0.30 | 0.26 | 0.30 | 0.30 | 0.32 | 0.35 | 0.31 | 0.23 | 0.29 |
| Inventory turnover | 1.61 | 1.56 | 1.44 | 1.81 | 1.46 | 1.61 | 1.76 | 1.55 | 1.20 | 1.57 |
| Days sales outstanding | 147d | 146d | 180d | 178d | 131d | 123d | 127d | 135d | 153d | 146d |
| Days inventory outstanding | 226d | 233d | 253d | 201d | 251d | 227d | 207d | 235d | 303d | 232d |
| Days payable outstanding | - | - | - | 323d | - | - | 308d | - | - | 340d |
| Cash conversion cycle | - | - | - | 56d | - | - | 26d | - | - | 38d |
| Valuation | ||||||||||
| P / E | 67.3x | 78.2x | 189.7x | 78.0x | 98.2x | 203.6x | 182.0x | - | 770.9x | 198.8x |
| P / B | - | - | - | 46.6x | 676.6x | 338.5x | 51.9x | 209.1x | - | 89.6x |
| P / S | 7.6x | 7.3x | 10.6x | 8.9x | 11.0x | 11.5x | 8.5x | 10.5x | 11.8x | 11.5x |
| EV / EBITDA | 44.3x | 54.3x | 107.3x | - | - | 97.5x | - | - | 203.3x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 0.1% | -0.8% | -18.9% | -15.3% | -8.0% | 27.1% | 16.0% | -5.3% | -20.3% | 1.4% |
| Revenue CAGR (3y) | -4.5% | -0.8% | -6.4% | -0.1% | -2.7% | -0.8% | 2.6% | 0.6% | -10.2% | 5.8% |
| Revenue CAGR (5y) | -1.3% | -1.9% | -5.7% | 3.1% | -1.3% | 3.2% | 6.2% | 3.2% | -2.4% | 3.9% |
| Gross profit growth (YoY) | -3.0% | -2.2% | -26.1% | -14.8% | -2.9% | 51.7% | 39.7% | -4.3% | -15.0% | 11.1% |
| Operating income growth (YoY) | 0.8% | -9.3% | -39.5% | 74.3% | - | 510.3% | 4.6% | 82.9% | -75.0% | 39.8% |
| Net income growth (YoY) | 0.5% | -18.7% | -19.2% | 107.5% | - | 350.0% | -6.1% | 75.8% | -74.1% | 43.5% |
| EPS growth (YoY) | 2.7% | -16.2% | -18.8% | 105.3% | - | 370.6% | -6.3% | 76.0% | -75.0% | 42.9% |
| EPS CAGR (3y) | - | 17.3% | -1.5% | 40.1% | 7.4% | -11.1% | -28.2% | - | -62.5% | -18.2% |
| EPS CAGR (5y) | - | -8.7% | -27.4% | 1.1% | -4.5% | -12.8% | -11.7% | - | -36.3% | -14.7% |
| FCF growth (YoY) | - | - | -68.7% | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | -28.9% | - | - | -3.5% | - | - | - | - |
| Book value growth (YoY) | - | - | - | -2.1% | -70.3% | - | 49.1% | 2933.3% | - | -60.4% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-06-30.
Business segments
$7.07B totalHealth And Wellness$2.70B · 38.2%
Household$2.00B · 28.3%
Lifestyle$1.30B · 18.4%
International$1.06B · 15.1%
Geographic
$7.10B totalUS$6.08B · 85.6%
Non Us$1.02B · 14.4%
Peer comparison
Same SIC group: Specialty Cleaning, Polishing and Sanitation Preparations
Comparing CLOROX CO /DE/ against the 4 most active filers in the same SIC group.
Dividends
$4.96/share trailing 12 months · +1.6% YoY
| Ex-date | Per share |
|---|---|
| Apr 22, 2026 | $1.2400 |
| Jan 28, 2026 | $1.2400 |
| Oct 22, 2025 | $1.2400 |
| Aug 13, 2025 | $1.2400 |
| Apr 23, 2025 | $1.2200 |
| Jan 29, 2025 | $1.2200 |
| Oct 23, 2024 | $1.2200 |
| Aug 14, 2024 | $1.2200 |
| Apr 23, 2024 | $1.2000 |
| Jan 23, 2024 | $1.2000 |
| Oct 24, 2023 | $1.2000 |
| Aug 8, 2023 | $1.2000 |
| Apr 25, 2023 | $1.1800 |
| Jan 24, 2023 | $1.1800 |
| Oct 25, 2022 | $1.1800 |
| Jul 26, 2022 | $1.1800 |
| Apr 26, 2022 | $1.1600 |
| Jan 25, 2022 | $1.1600 |
| Oct 26, 2021 | $1.1600 |
| Jul 27, 2021 | $1.1600 |
| Apr 20, 2021 | $1.1100 |
| Jan 26, 2021 | $1.1100 |
| Nov 3, 2020 | $1.1100 |
| Jul 28, 2020 | $1.1100 |